LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,836,352 | -2.6% | 4,050,218 | +2.3% | 1.35% | -14.0% |
| Q2 2023 | $16,265,497 | +264.4% | 3,957,542 | +78.2% | 1.57% | +359.9% |
| Q1 2023 | $4,463,868 | -36.0% | 2,220,830 | 0.0% | 0.34% | -24.3% |
| Q4 2022 | $6,973,406 | -38.0% | 2,220,830 | -1.1% | 0.45% | -37.9% |
| Q3 2022 | $11,252,000 | -16.0% | 2,245,830 | -5.2% | 0.73% | +8.5% |
| Q2 2022 | $13,389,000 | – | 2,369,668 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
| Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
| Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
| Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
| Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
| RA Capital Management | 815,849 | $9,301,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
| Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |